![M. Pauliina Margolis](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
M. Pauliina Margolis
Directeur Technique/Scientifique/R&D chez Keystone Heart Ltd.
Profil
M.
Pauliina Margolis is currently the Chief Medical Officer & Vice President at Keystone Heart Ltd.
She previously worked as the VP-Scientific Affairs & Medical Director at Philips Image Guided Therapy Corp.
She obtained a doctorate degree from the University of Cincinnati (Ohio).
Postes actifs de M. Pauliina Margolis
Sociétés | Poste | Début |
---|---|---|
Keystone Heart Ltd.
![]() Keystone Heart Ltd. Medical SpecialtiesHealth Technology Keystone Heart Ltd. engages in the development and manufacture of cerebral embolic protection devices that aim to reduce the risk of stroke, neurocognitive decline, and dementia caused by brain damage associated with cardiovascular procedures. The company was founded by Dov V. Shimon in 2004 and is headquartered in Caesarea, Israel. | Directeur Technique/Scientifique/R&D | 25/04/2012 |
Anciens postes connus de M. Pauliina Margolis
Sociétés | Poste | Fin |
---|---|---|
VOLCANO CORPORATION | Directeur Technique/Scientifique/R&D | - |
Formation de M. Pauliina Margolis
University of Cincinnati (Ohio) | Doctorate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 2 |
---|---|
Philips Image Guided Therapy Corp.
![]() Philips Image Guided Therapy Corp. Medical SpecialtiesHealth Technology Volcano Corp. designs, develops and manufactures a broad suite of intravascular ultrasound products. The company was founded by Olav B. Bergheim and Samuel Ward Casscells and is headquartered in San Diego, CA. | Health Technology |
Keystone Heart Ltd.
![]() Keystone Heart Ltd. Medical SpecialtiesHealth Technology Keystone Heart Ltd. engages in the development and manufacture of cerebral embolic protection devices that aim to reduce the risk of stroke, neurocognitive decline, and dementia caused by brain damage associated with cardiovascular procedures. The company was founded by Dov V. Shimon in 2004 and is headquartered in Caesarea, Israel. | Health Technology |